HK Stock Market Move | Some pharmaceutical stocks rose in the afternoon, with CANSINOBIO (06185) up more than 10% and JUNSHI BIO (01877) up more than 5%.
Some pharmaceutical stocks rose in the afternoon. As of the time of writing, Kangxi Biological (06185) rose by 10.13% to HKD 40.86, and Junshi Biosciences (01877) rose by 5.19% to HKD 23.92.
Some pharmaceutical stocks rose in the afternoon. As of the time of writing, CANSINOBIO (06185) rose by 10.13%, to 40.86 Hong Kong dollars; JUNSHI BIO (01877) rose by 5.19%, to 23.92 Hong Kong dollars; FUDANZHANGJIANG (01349) rose by 4.11%, to 3.29 Hong Kong dollars.
On the news front, on January 26th, topics related to the Nipah virus epidemic in India surged on social media, attracting attention. According to Xinhua News Agency, India is experiencing a Nipah virus epidemic. Neighboring countries are on high alert. The infected are concentrated in the state of West Bengal, India. As of the time of writing, there have been 5 confirmed cases of infection, at least one of whom is in critical condition, with nearly 100 others requested to self-isolate at home.
Public information shows that Nipah is an RNA virus that can infect both humans and animals, mainly carried by fruit bats and pigs, with a mortality rate between 40% and 75%, and an incubation period typically ranging from 4 to 14 days. Currently, there is no specific vaccine or effective treatment, with treatment focusing on symptom control and supportive care.
Related Articles

Guosen: The hotel industry enters a new cycle as leading players reshaping their growth value.

New Stock News | Tumor drug manufacturer Deshengji Medicine plans to list in Hong Kong with a target fundraising amount of $200 million.

HK Stock Market Move | Partial real estate stocks rise in the afternoon, market attention on real estate chain heating up, institutions say to pay attention to early favorable signals in real estate industry.
Guosen: The hotel industry enters a new cycle as leading players reshaping their growth value.

New Stock News | Tumor drug manufacturer Deshengji Medicine plans to list in Hong Kong with a target fundraising amount of $200 million.

HK Stock Market Move | Partial real estate stocks rise in the afternoon, market attention on real estate chain heating up, institutions say to pay attention to early favorable signals in real estate industry.

RECOMMEND

Paul Chan Says Hong Kong Has Licensed 11 Virtual Asset Exchanges, Stablecoin Licenses Expected Later This Year
22/01/2026

Ministry Of Finance And Other Departments Introduce Comprehensive Fiscal And Financial Policies To Boost Domestic Demand
22/01/2026

Capital Migration: Five Years On, An In‑Depth Analysis Of China’s 11 High‑Growth Venture Capital Tracks In 2025
22/01/2026


